Stay updated with breaking news from Thyrocare Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The diagnostics industry led by national-level players like Lal Pathlabs, Metropolis Healthcare, Thyrocare Technologies, SRL, Vijaya Diagnostic Centre, Krsnaa Diagnostics, saw a sharp 74% jump in revenue in April-September
(Bloomberg) -- The first pill to treat Covid-19 is on its way and vaccine producers are rolling out booster shots in wealthy countries. For investors, the next stage of the pandemic means a tougher landscape for stockpicking. The success of Merck & Co.’s oral antiviral treatment in a clinical trial has shifted the momentum in the stock market, weighing on shares of the companies that developed the most effective vaccines, Moderna Inc. and the duo of Pfizer Inc. and BioNTech SE. Nineteen months into the pandemic, a successful rollout of a Covid-19 pill could quicken and broaden the world’s ...
The representation is being given by South Chemists & Distributors Association (SCDA) which says that the proposed acquisition needs to be rejected by the CCI Allowing PharmEasy to acquire Thyrocare which has a wide presence in the diagnostics market would give the company an unfair advantage, said the SCDA Besides calling epharmacies illegal, the SCDA also claimed that the only reason for the adoption of epharmacies is that they offer discounts Healthtech unicorn PharmEasy’s proposed acquisition of Thyrocare, which is subject to regulatory approval, is likely to face a legal challenge at t...
Will Section 66A finally be laid to rest? Want this newsletter delievered to your inbox? SUBSCRIBE Thank you for subscribing to Unwrapped We'll soon meet in your inbox. / Unwrapped Last Monday, the Supreme Court of India said it was “shocked” that police across the country continue to charge people under Section 66A of the Information Technology Act, a law it struck down as unconstitutional in March 2015. “You file a counter as it is a shocking state of affairs,” Justice Rohinton Fali Nariman told Attorney General KK Venogopal, who sought two weeks to reply. Will 2021 be the year t...
Conquering outpatient care: can Thyrocare help PharmEasy cement its top position in digital health? ✖ From left, Siddharth Shah, cofounder & CEO, API Holdings Ltd shakes hands with A Velumani, chairman & managing director, Thyrocare after signing the agreement of acquisition; image courtesy of PharmEasy Synopsis PharmEasy seems to have cemented its position as India’s largest online pharmacy firm with the addition of Thyrocare. It now has a diversified portfolio of offerings and a strong back-end support. With this added muscle, the more than six-year-old startup is now ready to compete...